BNTC · Benitec Biopharma Inc
United States · RS rating 19 · As of 2026-11-03
| Price | 8.40 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 37 / 17 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 7 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -18.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +47.0% |
| Market cap (USD) | $435.0M |